| Dean Palanca Ouano, MD | |
|
802 Mccarthy Blvd, New Bern, NC 28562-5236 | |
| (252) 633-4183 | |
| (252) 636-1674 |
| Full Name | Dean Palanca Ouano |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 802 Mccarthy Blvd, New Bern, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811911316 | NPI | - | NPPES |
| 64027 | Other | NC | BCBS |
| 8964027 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 9400604 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolina East Medical Center | New bern, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Eye Clinic, Pa | 6103811716 | 6 |
News Archive
The discovery of a new reset button for the brain's master biological clock could eventually lead to new treatments for conditions like seasonal affective disorder, reduce the adverse health effects of working the night shift and possibly even cure jet lag.
On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.
DelMar Pharmaceuticals, Inc. today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor.
The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.
› Verified 5 days ago
| Entity Name | Coastal Eye Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255355814 PECOS PAC ID: 6103811716 Enrollment ID: O20040414001763 |
News Archive
The discovery of a new reset button for the brain's master biological clock could eventually lead to new treatments for conditions like seasonal affective disorder, reduce the adverse health effects of working the night shift and possibly even cure jet lag.
On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.
DelMar Pharmaceuticals, Inc. today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor.
The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dean Palanca Ouano, MD 802 Mccarthy Blvd, New Bern, NC 28562-5236 Ph: (252) 633-4183 | Dean Palanca Ouano, MD 802 Mccarthy Blvd, New Bern, NC 28562-5236 Ph: (252) 633-4183 |
News Archive
The discovery of a new reset button for the brain's master biological clock could eventually lead to new treatments for conditions like seasonal affective disorder, reduce the adverse health effects of working the night shift and possibly even cure jet lag.
On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.
DelMar Pharmaceuticals, Inc. today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor.
The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.
› Verified 5 days ago
Andrew Davidson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3515 Trent Rd, Suite 9, New Bern, NC 28562 Phone: 252-514-2155 Fax: 252-514-0303 | |
Bettina Bass Meekins, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 802 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-4183 Fax: 252-636-1674 | |
Dr. Shil Kiritkumar Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1403 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-5100 Fax: 252-633-5150 | |
Dr. Michele Lea Scott, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 802 Mccarthy Blvd, Coastal Eye Clinic, New Bern, NC 28562 Phone: 252-633-4163 Fax: 252-636-1674 | |
Dr. Jay A Singleton, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3515 Trent Rd, Suite 9, New Bern, NC 28562 Phone: 252-514-2155 Fax: 252-514-0303 | |
James Kenneth Chance, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 802 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-4183 Fax: 252-636-1674 |